Completed
Multi-country Investigator-Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases (Trials4Health 2026)
The Research Council of Norway and the Regional Health Authorities jointly announce 1.2 million euros for transnational investigator-initiated clinical trials
The aim of the call is to support and enable transnational collaboration between clinical research communities on investigator-initiated clinical trials.
The studies for which funding is sought must:
- deal with cardiovascular, autoimmune or metabolic diseases
- be randomized
- be designed as pragmatic comparative-effictiveness studies and/or drug repuposing studies
ECRIN (European Clinical Research Infrastructure Network) offers support to the planning and conduct of multinational clinical studies and must be contacted by 30 November 2025 if this support if wanted. By using ECRIN services your project is eligible for additional funding, adding 15% to your budget. Contact Norwegian node in ECRIN for this; NorCRIN and European Correspondent Sigrun M. Hjelle, sighje@helse-bergen.no.